FDA Mandate On Rx Firms Would Protect Reimportation Under Senate Bill
This article was originally published in The Pink Sheet Daily
Executive Summary
The legislation requires drug manufacturers to notify FDA of any manufacturing changes that might circumvent reimportation. Bill sponsors include Dorgan, Kennedy and McCain.
You may also be interested in...
Health Committee Hearings To Focus On HHS Importation Report
The committee will also hold hearings on the Dorgan/Snowe importation bill by the end of April. The legislation, which differs from legislation introduced by the senators last year, is backed by Finance Committee Chairman Grassley.
Health Committee Hearings To Focus On HHS Importation Report
The committee will also hold hearings on the Dorgan/Snowe importation bill by the end of April. The legislation, which differs from legislation introduced by the senators last year, is backed by Finance Committee Chairman Grassley.
Four Senate Bills Signal Start Of 2005 Rx Importation Debate
Two partisan bills will compete with the reintroduction of the Dorgan/Snowe bill and the Pharmaceutical Market Access Act passed by the House in 2003. The Senate Health Committee plans to hold a hearing on the Dorgan/Snowe bill within 90 days.